Medical Net reports mixed Q3, adjusts strategy with divestiture

Medical Net (TSE:3645) reported its third quarter 2025 financial results, revealing a 21.0% year-over-year increase in revenue to JPY 4,421 million but a 74.3% decrease in operating profit to JPY 59 million. The company attributed a net loss of JPY 145 million to underperforming results from its "unspecified disease/prevention platform business" and a JPY 133 million impairment loss related to fixed assets held by Mirtel, a subsidiary.